by Summary:
[unable to retrieve full-text content]On The Increasingly Unfortunate Economics Of Peanut Allergies…: Things get awkward when companies decide to maximize profit, if for no other reason than it highlights where policy makers have procrastinated on regulation in hopes that self-interested oganizations would just behave.
Topics:
Jodi Beggs considers the following as important: Economics, epipen, Healthcare, Monopoly
This could be interesting, too:
[unable to retrieve full-text content][unable to retrieve full-text content]On The Increasingly Unfortunate Economics Of Peanut Allergies…: Things get awkward when companies decide to maximize profit, if for no other reason than it highlights where policy makers have procrastinated on regulation in hopes that self-interested oganizations would just behave.
Topics:
Jodi Beggs considers the following as important: Economics, epipen, Healthcare, Monopoly
This could be interesting, too:
Angry Bear writes A Doctor at Cigna Said Her Bosses Pressured Her to Review Patients’ Cases Too Quickly
Lars Pålsson Syll writes Economics — a dismal and harmful science
NewDealdemocrat writes Coronavirus dashboard, 4 years into the pandemic: all-time low in hospitalizations, deaths likely to follow
Bill Haskell writes Nestlé adds sugar to baby food in low-income countries, report finds . . .
On The Increasingly Unfortunate Economics Of Peanut Allergies…:
Things get awkward when companies decide to maximize profit, if for no other reason than it highlights where policy makers have procrastinated on regulation in hopes that self-interested oganizations would just behave.